Agilex has offered our clients small molecule solutions that lead to their success. Agilex Biolab...
15
Jun
Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decade...
We took some time to sit down and talk with Cameron so you could get to know him a bit better......
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug dis...
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services....
Small and large molecule drug development often necessitates distinct analytical methodologies. Agil...
Agilex has extensive experience developing and validating like-binding assays for specific immune-on...
How do Australia's streamlined regulatory process and global tax incentive apply to your toxicology...
作为 Healius 网络的一部分，Agilex Biolabs 公司继续进行全球扩张和企业发展，斯蒂芬-麦金太尔（Stephen McIntyre）被选为公司首席执行官。
by Kurt Sales The rise of Cell and Gene Therapy products is increasingly becoming more prevalent....
Agilex Biolabs expands with a new Flow Cytometry Laboratory at QIMR Berghofer, boosting speed and precision in clinical research.
Contracted by the South Australian Government, Agilex Biolabs is deploying world-class science to sa...
Introduction – A New Chapter in Drug Development The use of biomarkers in medicine is not new....
By Dr Hayley Kain, Pharmacokinetic Scientist at Agilex Biolabs Rapid Data. Smarter Decisions. No...
By Dr. Kurt Sales, CSO Section Summary: How Agilex has emerged as a leader to support the ris...
By Dr. Kurt Sales, CSO Summary The following article focuses on the use of flow cytometry in c...
By William Grenfell, Head of IT In today's digital age, information security is paramount. At Agi...
By Kim Salvatore, Head of Client and Operational Services The bioanalytical and drug development...
Research shows that Biotechnology companies have been facing significant challenges – with continu...
By Dr. Kurt Sales, CSO Introduction Immunological assays are essential in drug development, es...
